NAFDAC alerts public of counterfeit Dostinex tablet in circulation

The National Agency for Food and Drugs Administration and Control (NAFDAC) has alerted the public of a counterfeit Dostinex (Cabergolin) 0.5mg tablet in circulation. NAFDAC issued the alert on its website, following the notification received from Pfizer Specialties Limited,